Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Assets (2021 - 2025)

Historic Return on Assets for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q3 2025 value amounting to 0.61%.

  • Bolt Biotherapeutics' Return on Assets fell 100.0% to 0.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.52% for FY2024, which is 1700.0% down from last year.
  • Per Bolt Biotherapeutics' latest filing, its Return on Assets stood at 0.61% for Q3 2025, which was down 100.0% from 0.63% recorded in Q2 2025.
  • Bolt Biotherapeutics' Return on Assets' 5-year high stood at 0.16% during Q2 2021, with a 5-year trough of 0.68% in Q1 2025.
  • Its 5-year average for Return on Assets is 0.42%, with a median of 0.39% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -100bps in 2023, then tumbled by -2400bps in 2024.
  • Quarter analysis of 5 years shows Bolt Biotherapeutics' Return on Assets stood at 0.23% in 2021, then tumbled by -61bps to 0.37% in 2022, then dropped by -11bps to 0.41% in 2023, then plummeted by -57bps to 0.65% in 2024, then increased by 6bps to 0.61% in 2025.
  • Its Return on Assets was 0.61% in Q3 2025, compared to 0.63% in Q2 2025 and 0.68% in Q1 2025.